To the full analysis
Fertilisers And Chemicals Travancore stock: growth
FACT.NSFertilisers And Chemicals Travancore reported $608.37M in revenue for fiscal 2026, up 134.6% on the prior year, up 20.6% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
9.2%
per year from 2007 to 2026, per share 9.2%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2007 | |
|---|---|---|---|
| Revenue | 20.6% | 16.8% | 9.2% |
| Revenue per share | 20.5% | 16.7% | 9.2% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $113.43M | −$13.26M | −$14.56M |
| 2008 | $61M | $953.21K | −$10.96M |
| 2009 | $76.34M | $4.57M | −$5.58M |
| 2010 | $117M | −$11.04M | −$17.85M |
| 2011 | $138.33M | −$5.24M | $13.95M |
| 2012 | $171.13M | $2.1M | $13.91M |
| 2013 | $149.77M | −$37.62M | −$15.1M |
| 2014 | $146.46M | −$28.16M | $1.81M |
| 2015 | $141.15M | −$39.63M | $19.38M |
| 2016 | $129.23M | −$48.74M | −$25.6M |
| 2017 | $137.53M | −$27.92M | $2.52M |
| 2018 | $143.52M | −$13.72M | $22.82M |
| 2019 | $145.41M | $17.29M | −$43.6M |
| 2020 | $202.49M | $103.68M | $18.1M |
| 2021 | $238.34M | $37.25M | $105.04M |
| 2022 | $289M | $36.82M | $9.35M |
| 2023 | $335.4M | $65.14M | $57.92M |
| 2024 | $312.38M | $13.63M | $13.14M |
| 2025 | $259.3M | $4.38M | $17.51M |
| 2026 | $608.37M | −$4.21M | −$96.41M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ₹94.0836)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 6 Dec 2024)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.